Skip to content

Updates

Explore our latest insights, regulatory updates, and strategic reports for the life sciences sector.

Pharmaceuticals Commercial Contracts Testimonial

We have negotiated clinical trial agreements on behalf of several sponsors.

Medical Devices Commercial Contracts Regulatory Compliance and Enforcement Testimonial

We have advised on commercial contracting and borderline classification cases.

Medical Devices Commercial Contracts Regulatory Compliance and Enforcement Testimonial

We have advised an importers, distributors on a complex international supply chain strategy under the MDR.

Healthcare Commercial Contracts Regulatory Compliance and Enforcement Testimonial

We have advised a large MedTech company on the structuring of its collaboration with Dutch healthcare providers and healthcare professionals for clinical research and product development purposes.

Chemicals Regulatory Compliance and Enforcement Spin-out and Starter Advisory Testimonial

We have advised a start-up on the legal limitations and requirements related to the transport of dangerous substances.

Cosmetics Commercial Contracts Testimonial

Our team negotiated a cooperation agreement between a cosmetics brand owner and a manufacturer on behalf of a mid-sized company.

Cosmetics Commercial Contracts Testimonial

Our team assisted a mid-sized cosmetics company with the negotiation of a distribution agreement.

Biotech Pharmaceuticals Commercial Contracts Intellectual Property and Licensing Testimonial

Axon advised a stock-listed biopharmaceutical company on antibody licensing and technology transfer agreements with two major US-based pharmaceutical companies. The deals involved the grant of commercial rights to the licensor's proprietary antibody platform technology.

Biotech Corporate, Governance and Boardroom Counselling Intellectual Property and Licensing Spin-out and Starter Advisory Testimonial

Axon regularly advises spin-outs from academic institutions on a wide range of topics. We make sure that the spin-out’s license agreement includes commercially and legally viable terms and is attractive to investors. In addition, we advise on the corporate structure of the spin-out, balancing the interest of the founders, the academic institution and all other stakeholders.